We report the development of a tertiary amine-containing β-turn peptide that catalyzes the atroposelective bromination of pharmaceutically relevant 3-arylquinazolin-4 (3 H)-ones (quinazolinones) with high levels of enantioinduction over a broad substrate scope. The